MTOR and neoplasm: In summary, G-CSF can activate the PI3K/AKT/mTOR signaling pathway by inhibiting SHP2 activation in tumor-associated macrophages, and promoting the proliferation, migration, and angiogenesis of hepatocellular carcinoma cells, leading to the progression of hepatocellular carcinoma.